For the purposes of this study, all case physicians who were intervened with in the study were eliminated from the control groups.
The studies were eliminated for being duplicates (n = 1), letters, reviews, or meta-analyses (n = 11), not human studies (n = 14), not related to research topics (n = 18), not case-control study (n = 8), not relevant to MRI-DWI (n = 12), and not relevant to renal tumors (n = 15) and having insufficient information or weakly correlated data (n = 2).
However, because these genes were sequenced de novo in our investigation, the possibility of cross or non-specific hybridization that could have occurred in the previous study was eliminated, providing stronger evidence for involvement of these genes in rhizome-specific processes.
Population-attributable proportions estimate the reduction in incidence of a disease if the exposure under study was eliminated from the population (e.g., by vaccination).
Because it was not possible to determine whether records identified in fiscal year 2003/04 were the initial hospitalization for a brain tumour (due to the lack of data to look back at least 1 year), this fiscal year of study was eliminated from the patient level analysis.
Heterogeneity among the included studies was eliminated by subgroup analysis (I = 14%, P = 0.28).
Heterogeneity among the included studies was eliminated by performing subgroup analysis.
One subject was eliminated from the study since she discontinued her lifestyle modification by consuming a high fat diet routinely after starting the mulberry leaf tablet regimen.
Eight of the completed studies and 3 of the ongoing studies were eliminated after full-text reading of the papers (Additional file 3: Table S3: the excluded trials and the reasons for exclusion).
It is strongly recommended that either the mouse studies are eliminated from the paper or substantially clarified to overcome these concerns.
